Building MHC class II epitope predictor using machine learning approaches.

Clicks: 313
ID: 100979
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #50 of 139 articles by views in methods in molecular biology (clifton, nj)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 139 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Identification of T-cell epitopes binding to MHC class II molecules is an important step in epitope-based vaccine development. This process has since been accelerated with the use of bioinformatics tools to aid in the prediction of peptide binding to MHC class II molecules and also to systematically scan for candidate peptides in antigenic proteins. There have been many prediction software developed over the years using various methods and algorithms and they are becoming increasingly sophisticated. Here, we illustrate the use of machine learning algorithms to train on MHC class II peptide data represented by feature vectors describing their amino acid physicochemical properties. The developed prediction model can then be used to predict new peptide data.
Reference Key
eng2015buildingmethods Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Eng, Loan Ping;Tan, Tin Wee;Tong, Joo Chuan;
Journal methods in molecular biology (clifton, nj)
Year 2015
DOI
10.1007/978-1-4939-2285-7_4
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.